Clinical Data Updates On Edwards' Transcatheter Mitral, Tricuspid Programs Presented At EuroPCRPRNewsWire • 05/18/21
Edwards Lifesciences (EW) Surges 6.3%: Is This an Indication of Further Gains?Zacks Investment Research • 04/22/21
Edwards Lifesciences and Intuitive Surgical: Right Place, Right Time and Wide MoatsGuruFocus • 04/21/21
Providence Partners with Edwards Lifesciences, Cities of Irvine, Santa Ana, Costa Mesa and Tustin to Open Two Free Mass COVID-19 Vaccination ClinicsPRNewsWire • 04/21/21
Edwards Lifesciences Corporation (EW) CEO Mike Mussallem on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 04/21/21
Edwards Lifesciences (EW) Q1 Earnings and Revenues Surpass EstimatesZacks Investment Research • 04/20/21
Edwards Lifesciences Adds To Breakout After Smashing First-Quarter EstimatesInvestors Business Daily • 04/20/21
AMD, Boston Scientific, Intel, Nvidia and More Thursday Afternoon Analyst Calls24/7 Wall Street • 04/15/21
Edwards RESILIA Tissue Aortic Valve Demonstrates Favorable Safety and Efficacy at Five YearsPRNewsWire • 01/31/21
Edwards Lifesciences Corporation (EW) CEO Mike Mussallem on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 01/28/21
Edwards Lifesciences: TAVR, Mitral And Tricuspid Segments Are Each Meaningful CompoundersSeeking Alpha • 01/11/21
Edwards Treats First Patient In U.S. Clinical Trial Evaluating Minimally Invasive Device For Mitral Valve DiseasePRNewsWire • 12/21/20